Clinical Trial Update: Safety and Efficacy Study of Angiotech Central Venous Catheter to Prevent Bacterial Catheter Colonization [Phase 3]

View source ↗

Summary

A Phase 3 trial assessing the safety and efficacy of the Angiotech Central Venous Catheter to prevent bacterial catheter colonization has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Catheter-related Bloodstream Infection

Drugs mentioned

• Angiotech Central Venous Catheter

Snippet

Sponsor: Angiotech Pharmaceuticals | Conditions: Bacterial Infections | Phase 3 | Status: COMPLETED